Mathew Nightingale

1.4k citations
14 papers · 625 indexed · h-index 10

Mathew Nightingale

13 papers receiving 613 citations

Peers

Mathew Nightingale
Comparison fields: 5 of 73
  • Hematology 197
  • Genetics 94
  • Clinical Biochemistry 58
  • Molecular Biology 387
  • Rheumatology 67
Replace Frédéric Esnard with:
Frédéric Esnard France
Andrea Šoltýsová Slovakia
Yaping Sun United States
Stephen P. Burr United Kingdom
Michael W. Harr United States
Pushpankur Ghoshal United States
Nicole Taub Austria
Chyuan-Sheng Lin United States
Stefan Lang Sweden
Gui Gao United States
Mathew Nightingale relative to Frédéric Esnard France Frédéric Esnard's profile →
Citations per field
00.5×10×12.7×
Frédéric Esnard · 1×
Citations per year

Countries citing papers authored by Mathew Nightingale

Since Specialization
Citations

This map shows the geographic impact of Mathew Nightingale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Nightingale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Nightingale more than expected).

Fields of papers citing papers by Mathew Nightingale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew Nightingale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Nightingale. The network helps show where Mathew Nightingale may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mathew Nightingale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathew Nightingale Line = papers co-authored together Mathew Nightingale links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20252
2 202213
3 20212
4 20210
5 201632
6 201322
7
Mutations in a novel serine protease PRSS56 in families with nanophthalmos.
201143
8 201052
9 200961
10 200912
11 2009181
12 2007100
13 2006104
14 20061

About Mathew Nightingale

Mathew Nightingale is a scholar working on Clinical Biochemistry, Geriatrics and Gerontology and Hematology, having authored 14 papers that have together received 625 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (2 papers), Metabolism and Genetic Disorders (2 papers), Hereditary Neurological Disorders (2 papers), Protein Degradation and Inhibitors (2 papers), Polyomavirus and related diseases (2 papers), Genetic Neurodegenerative Diseases (2 papers), Peptidase Inhibition and Analysis (2 papers) and Folate and B Vitamins Research (2 papers). The work is most often cited by research in Hematology (197 citations), Genetics (94 citations) and Clinical Biochemistry (58 citations). Mathew Nightingale has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Haiyan Jiang, Andrew Orr, Mark D. Ludman, Makoto Matsuoka, Duane L. Guernsey, Susan C. Evans, Meghan Ferguson, Andrea L. Rideout, Karen Bedard and Mark Samuels. Their work appears in journals such as Nature Genetics, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026